Editorial: Drug Repositioning: Current Advances and Future Perspectives

The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations

(2018) Alexandra B. Keenan et al.   Cell Systems

The Drug Repurposing Hub: a next-generation drug library and information resource

(2017) Steven M Corsello et al.   NATURE MEDICINE

DrugBank 5.0: a major update to the DrugBank database for 2018

(2017) David S Wishart et al.   NUCLEIC ACIDS RESEARCH

Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data

(2017) Amar Koleti et al.   NUCLEIC ACIDS RESEARCH

Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment

(2017) A B Nagaraj et al.   ONCOGENE

Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer

(2017) Xiaoyu Wang et al.   Oncotarget

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy

(2017) Kenji Ikemura et al.   Frontiers in Pharmacology

A standard database for drug repositioning

(2017) Adam S. Brown et al.   Scientific Data

In silico methods to address polypharmacology: current status, applications and future perspectives

(2016) Antonio Lavecchia et al.   DRUG DISCOVERY TODAY

Can you teach old drugs new tricks?

(2016) Nicola Nosengo   NATURE

OUP accepted manuscript

(2016)   NUCLEIC ACIDS RESEARCH

Open Targets: a platform for therapeutic target identification and validation

(2016) Gautier Koscielny et al.   NUCLEIC ACIDS RESEARCH

The ChEMBL database in 2017

(2016) Anna Gaulton et al.   NUCLEIC ACIDS RESEARCH

DrugCentral: online drug compendium

(2016) Oleg Ursu et al.   NUCLEIC ACIDS RESEARCH

Integrated Approaches to Drug Discovery for Oxidative Stress-Related Retinal Diseases

(2016) Yuhei Nishimura et al.   Oxidative Medicine and Cellular Longevity

PLIP: fully automated protein–ligand interaction profiler

(2015) Sebastian Salentin et al.   NUCLEIC ACIDS RESEARCH

PubChem Substance and Compound databases

(2015) Sunghwan Kim et al.   NUCLEIC ACIDS RESEARCH

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment

(2015) Eddy Pasquier et al.   Oncotarget

Drug repurposing and the prior art patents of competitors

(2014) Christian Sternitzke   DRUG DISCOVERY TODAY

ProBiS-ligands: a web server for prediction of ligands by examination of protein binding sites

(2014) Janez Konc et al.   NUCLEIC ACIDS RESEARCH

Use of Statins and the Risk of Death in Patients With Prostate Cancer

(2013) Oriana Yu et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents

(2012) M. Thurnher et al.   CLINICAL CANCER RESEARCH

Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancer

(2012) David Loven et al.   DRUG DISCOVERY TODAY

Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined with the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer

(2010) Kae Hashimoto et al.   MOLECULAR CANCER THERAPEUTICS

Data completeness—the Achilles heel of drug-target networks

(2008) Jordi Mestres et al.   NATURE BIOTECHNOLOGY